What is Jacksoneye?
Jacksoneye operates as a multi-disciplinary ophthalmology platform, delivering a sophisticated suite of vision care services. The organization distinguishes itself through a clinical focus on high-complexity procedures, including advanced retina care, refractive surgery, and pediatric ophthalmology. By leveraging state-of-the-art diagnostic equipment and a team of specialized surgeons, the company addresses a broad spectrum of ocular pathologies, from chronic dry eye management to urgent emergency interventions. The firm's operational philosophy centers on a patient-centric delivery model, which has proven effective in fostering long-term patient retention and clinical outcomes within the competitive healthcare services sector.
How much funding has Jacksoneye raised?
Jacksoneye has raised a total of $346K across 2 funding rounds:
Debt
$150K
Debt
$196K
Debt (2020): $150K with participation from PPP
Debt (2021): $196K led by PPP
Key Investors in Jacksoneye
PPP
Public-Private Partnership
What's next for Jacksoneye?
With the successful closure of this major strategic investment, Jacksoneye is poised to accelerate its expansion into new geographic markets and enhance its technological infrastructure. The firm's roadmap likely includes the acquisition of smaller, specialized clinics to consolidate its market share and the implementation of proprietary digital health tools to streamline patient intake and post-operative monitoring. As the company matures, the focus will shift toward optimizing operational efficiencies and scaling its refractive surgery volume, ensuring that it remains at the forefront of the ophthalmology industry. This growth phase is critical for establishing a sustainable competitive advantage in an increasingly consolidated healthcare landscape.
See full Jacksoneye company page
